1 The localization of brain sites where bradykinin (BK) induces its antinociceptive eect in rats, was studied using as index the threshold for the jaw-opening re¯ex elicited by the dental pulp electrical stimulation test (DPEST). 2 The microinjection of BK into the lateral or fourth cerebral ventricles induced an antinociceptive eect, with Index of Antinociception (IA) of 0.51+0.03 and 0.68+0.05, respectively. However, microinjections of the peptide into the third ventricle induced a less marked antinociception (IA=0.28+0.08). 3 The brain sites where the microinjection of BK caused an antinociceptive eect were: locus coeruleus, principal nucleus, oral part of the spinal sensorial trigeminal nucleus, and the sensory root of the trigeminal nerve. 4 The antinociceptive eect was more intense when BK (4 ± 16 nmol) was injected into the locus coeruleus. Microinjection of BK (4 nmol) into the fourth ventricle, but not into the locus coeruleus, induced an increase in blood pressure. The microinjection of the peptide into the nucleus tractus solitarius, a site that is also involved in the pressor eect of BK, did not induce an antinociceptive eect. These results indicate that the antinociceptive eect of BK is not related to blood pressure changes. 5 The microinjection of BK into some of the sites involved in the mechanisms of analgaesia, including the periaquenductal gray matter (dorsal, lateral and ventrolateral) and the dorsal raphe nucleus did not induce an antinociceptive eect. 6 The results suggest that the most likely brain sites involved in the antinociceptive eect of BK are the locus coeruleus and the principal sensory trigeminal nucleus. The present results did not exclude the involvement of other brain sites surrounding the lateral and the third ventricles.